CG Oncology

Public

Irvine, CaliforniaBiotechhttps://www.cgoncology.com

Last Round

Follow-on Offering

Dec 16, 2024

Total Funding Raised

$1.2B

Company Overview

CG Oncology (NAS: CGON) is a biopharmaceutical company dedicated to developing and commercializing innovative bladder-sparing therapies for patients with bladder cancer.

Sector

Biotech

AI Layer

Non-AI

Keywords

oncolytic immunotherapy for bladder cancerBCG-unresponsive NMIBC therapybladder-sparing cancer therapeuticNon-Muscle Invasive Bladder Cancer (NMIBC) treatmentengineered adenovirus therapeuticintravesically delivered immunotherapyoncolytic virus therapyclinical-stage biopharmaceuticalbladder cancer therapeuticsRb pathway-selective cancer therapy

CG Oncology Comps

Public and private peers based on sector, stage, and business model.

CG Oncology comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

CG Oncology Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Follow-on Offering	Dec 16, 2024
IPO Announced	Jan 24, 2024
Crossover Round	Aug 2, 2023
Crossover Financing	Aug 2, 2023
Series F	Jul 1, 2023
Series E	Nov 15, 2022

View all Funding Rounds

CG Oncology Investors

Notable investors and investment history

CG Oncology investors
Investor	Rounds
Sirona Capital	Series E
Longitude Capital	Series F, Crossover Financing, Crossover Round, Series E
Janus Henderson Group	Series F, Crossover Financing, Crossover Round
RA Capital Management	Series F, Crossover Financing, Crossover Round, Series E
TCG Crossover	Series F, Crossover Financing, Crossover Round
Morgan Stanley & Co., LLC	Follow-on Offering
Camford Capital	Series D

View all Investors

CG Oncology Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

CG Oncology Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersIrvine, California

Employee Range197

Year Founded2010

Last FundingDec 16, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.